Fleetwood Onsite Conference Recording - Conference presentation capture Contact  |  My Account  |  Cart Contents  |  Checkout   
  Home » OESO - World Organization for Specialized Studies on Diseases of the Esophagus » 12th OESO World Conference - 2013 » Sessions »

Previous Product  Product 38 of 39  Next Product   From: Sessions

 Topic Forum 6 - Evidence-based decision making in esophageal cancer $10.00   
Select Format:

Includes all of these presentations from this session:

# Presentation Speaker
1 What are the levels of evidence? H.H. Wang (Boston)
2 How is screening for esophageal squamous cell carcinoma performed in China? S. Dawsey (NCI, Bethesda)
3 Can endo-cytoscopy replace biopsy histology for squamous cell carcinoma? Y. Kumagai (Saitama)
4 Does the incidence of adenocarcinoma justify surveillance in individuals who have gastro-esophageal reflux disease or Barrett?s esophagus? J.M. Inadomi (Seattle)
5 Evidence-Based decision making in Esophageal Cancer J.M. Inadomi (Seattle)
6 What are the current nonendoscopic options for early detection and treatment of esophageal squamous cell carcinoma and its precursor lesions? S. Dawsey (NCI, Bethesda)
7 Is there a minimum number of lymph nodes from resected specimens required for accurate staging of the esophageal carcinoma? R.M. Najarian (Boston)
8 What is the clinical significance of post-therapy pathologic stage in patients with esophageal adenocarcinoma following preoperative chemoradiation? H.H. Wang (Boston)
9 What is the clinical significance of posttherapy pathologic stage in patients with esophageal squamous cell carcinoma following preoperative chemoradiation? Yin-Kai Chao (Taiwan)
10 Can stimulation of salivary and esophageal secretion of protective factors help to prevent RE, BE & adenocarcinoma sequelae in patients with gastro-esophageal reflux disease? J. Sarosiek (El Paso)


 Copyright © 2024 Fleetwood Onsite Conference Recording

Fleetwood Facebook Page Follow us on Twitter Fleetwood on YouTube